Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Viruses ; 14(11)2022 10 27.
Article in English | MEDLINE | ID: mdl-36366469

ABSTRACT

BACKGROUND: Human norovirus (HuNoV) is the leading viral cause of diarrhea, with GII.4 as the predominant genotype of HuNoV outbreaks globally. However, new genogroup variants emerge periodically, complicating the development of anti-HuNoV vaccines; other prophylactic or therapeutic medications specifically for HuNoV disease are lacking. Passive immunization using oral anti-HuNoV antibodies may be a rational alternative. Here, we explore the feasibility of using avian immunoglobulins (IgY) for preventing HuNoV infection in vitro in a human intestinal enteroid (HIE) model. METHODS: Hens were immunized with virus-like particles (VLP) of a GII.4 HuNoV strain (GII.4/CHDC2094/1974/US) by intramuscular injection. The resulting IgY was evaluated for inhibition of binding to histo-blood group antigens (HBGA) and viral neutralization against representative GII.4 and GII.6 clinical isolates, using an HIE model. RESULTS: IgY titers were detected by three weeks following initial immunization, persisting at levels of 1:221 (1:2,097,152) from 9 weeks to 23 weeks. Anti-HuNoV IgY significantly (p < 0.05) blocked VLP adhesion to HBGA up to 1:12,048 dilution (0.005 mg/mL), and significantly (p < 0.05) inhibited replication of HuNoV GII.4[P16] Sydney 2012 in HIEs up to 1:128 dilution (0.08 mg/mL). Neutralization was not detected against genotype GII.6. CONCLUSIONS: We demonstrate the feasibility of IgY for preventing infection of HIE by HuNoV GII.4. Clinical preparations should cover multiple circulating HuNoV genotypes for comprehensive effects. Plans for animal studies are underway.


Subject(s)
Blood Group Antigens , Caliciviridae Infections , Norovirus , Humans , Animals , Female , Chickens , Feasibility Studies , Caliciviridae Infections/prevention & control , Caliciviridae Infections/veterinary , Norovirus/genetics , Blood Group Antigens/genetics , Antibodies
2.
Avian Dis ; 56(4): 659-69, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23397836

ABSTRACT

Antimicrobial/host defense peptides (A/HDP) are natural compounds that are found in leucocyte cells and on the skin and bodily fluids of birds, reptiles, and mammals. Not only do they possess antibacterial, antiviral, and antiparasitic characteristics but they also stimulate the host immune system to combat infectious diseases and may play a role in the promotion of wound repair. Gamma-amino butyric acid (GABA) is an amino acid-based inhibitory neurotransmitter in the brain that has also been shown to promote wound healing on skin. The objective of this study was to establish a therapeutic cocktail that protects birds against Escherichia coli-related disease and lesions in broilers. We injected a cocktail of six A/HDPs with or without GABA into 3-wk-old broilers by a subcutaneous or intramuscular route followed 24 hr later by challenge with a field isolate of serogroup O2 E. coli. Birds were examined for 5-6 days post-E. coli challenge and clinical, pathologic, and bacteriologic assessments were conducted. Birds that were subcutaneously injected with an A/HDP plus GABA cocktail had significantly higher survival rates and lower levels of bacteremia (P < 0.05), but a similar percentage of the surviving birds had large cellulitis lesions compared to the surviving phosphate-buffered saline-injected control birds. When this cocktail was administered intramuscularly, there was a trend towards protection against E. coli-related death, although the results were not statistically significant and there was no reduction in bacteremia. A significant number of birds had a reduced bacterial load on cellulitis lesions but no reduction in lesion size, which suggests that when the cocktail was administered intramuscularly it failed to protect against cellulitis. These results suggest that the route of administration of the cocktail influences disease outcome. Gene expression analysis was performed to investigate whether the cocktail induced immunomodulatory functions in avian cells that complemented their antimicrobial and anti-endotoxic effects. A/HDP plus GABA mediated temporal induction of pro-inflammatory cytokines but no induction of any of the chemokines under investigation. This cocktail shows potential to protect against E. coli-related death, which is a major economic burden to the poultry industry.


Subject(s)
Antimicrobial Cationic Peptides/therapeutic use , Bacteremia/veterinary , Cellulitis/veterinary , Chickens , Escherichia coli Infections/veterinary , Poultry Diseases/prevention & control , gamma-Aminobutyric Acid/therapeutic use , Adjuvants, Immunologic/therapeutic use , Age Factors , Animals , Antimicrobial Cationic Peptides/administration & dosage , Antimicrobial Cationic Peptides/immunology , Bacteremia/microbiology , Bacteremia/prevention & control , Cellulitis/microbiology , Cellulitis/prevention & control , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Escherichia coli Infections/microbiology , Escherichia coli Infections/prevention & control , Gene Expression Regulation , Injections, Intramuscular/veterinary , Injections, Subcutaneous/veterinary , Macrophages/drug effects , Macrophages/immunology , Poultry Diseases/microbiology , Real-Time Polymerase Chain Reaction/veterinary , gamma-Aminobutyric Acid/administration & dosage , gamma-Aminobutyric Acid/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...